This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder

Mauricio Tohen, MD, DrPH, MBA; Joseph F. Goldberg, MD; Youssef Hassoun, MD; and Suresh Sureddi, MD

Published: April 15, 2021

Learn how simplifying a bipolar disorder treatment regimen, with a single agent acting as the “foundation” and others added when needed, may both improve patient morale and be effective for symptom control.

Read the full Academic Highlights

Quick Links: